Endologix to Report Third Quarter 2014 Financial Results on October 30, 2014
October 09, 2014 09:00 ET
|
Endologix
IRVINE, Calif., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the...
Endologix Announces Preliminary Third Quarter 2014 Revenue and Updates Financial Guidance
September 29, 2014 07:00 ET
|
Endologix
IRVINE, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today preliminary unaudited revenue...
Endologix Completes Enrollment in EVAS FORWARD - Global Registry
September 29, 2014 06:55 ET
|
Endologix
IRVINE, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient...
Endologix to Initiate First Ever Comparative Randomized EVAR Study
September 29, 2014 06:50 ET
|
Endologix
LEOPARD Study to Enroll 600 Patients to Provide a "Real-World" Head-to-Head Comparison of the AFX® System Versus Other Commercially Available EVAR Devices
IRVINE, Calif., Sept. 29, 2014...
Endologix to Present at Canaccord Genuity 34th Annual Growth Conference
August 05, 2014 16:05 ET
|
Endologix
IRVINE, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and...
Endologix Reports 13% Global Revenue Growth for the Second Quarter 2014
July 30, 2014 16:05 ET
|
Endologix
IRVINE, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...
Endologix to Report Second Quarter 2014 Financial Results on July 30, 2014
July 16, 2014 09:00 ET
|
Endologix
IRVINE, Calif., July 16, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the...
Endologix Achieves Revenue Milestone for the Nellix(R) EndoVascular Aneurysm Sealing System
June 17, 2014 09:00 ET
|
Endologix
IRVINE, Calif., June 17, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has achieved $10 million...
Endologix to Present at Jefferies 2014 Global Healthcare Conference
May 28, 2014 09:00 ET
|
Endologix
IRVINE, Calif., May 28, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and...
Endologix to Participate in Two Investor Conferences in May
May 02, 2014 09:00 ET
|
Endologix
IRVINE, Calif., May 2, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chairman and...